PTGS2 and neoplasm: Given that both 5-LOX and COX-2 are upregulated in inflammation-related tumors, the concomitant inhibition of 5-LOX and COX-2 was designed to render more potent tumor suppression than inhibition of a single eicosanoid pathway [116, 238, 239].